• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Preparation, characterization and performance evaluation of neomycin-HSA microspheres.

作者信息

Pande S, Vyas S, Dixit V

机构信息

Department of Pharamceutical Sciences, Dr. H. S. Gour Viswavidyalaya Sagar, India.

出版信息

J Microencapsul. 1990 Apr-Jun;7(2):155-65. doi: 10.3109/02652049009021828.

DOI:10.3109/02652049009021828
PMID:2329442
Abstract

Human serum albumin microspheres containing neomycin sulphate were prepared using emulsion polymerization and polymer dispersion techniques. The many variables which may affect the shape, size, stability, release of the drug from the microspheres such as internal phase to external phase volume ratio, human serum albumin content, stirring rate, polymer content and stabilizing agent concentration, were studied. Unlike the microspheres prepared by the emulsion polymerization technique, polymer dispersion stabilised microspheres were uniform in size and shape with a narrow range of size distribution. In vitro release of neomycin sulphate from albumin microspheres was studied using the dialysis cell method. The drug release from microspheres followed Q versus (t)-1/2 linear relationship. The in vivo distribution studies on prepared microspheres revealed that the localization takes place preferably in lung tissues, liver, spleen and kidney and is found to be dependent on the microsphere size. On administration of microspheres of 3-6 microns size, approximately 55 per cent of administered drug could be localized in the lungs.

摘要

相似文献

1
Preparation, characterization and performance evaluation of neomycin-HSA microspheres.
J Microencapsul. 1990 Apr-Jun;7(2):155-65. doi: 10.3109/02652049009021828.
2
Hydroxy-urea bearing albumin microspheres--preparation, characterization and evaluation.
J Microencapsul. 1991 Jan-Mar;8(1):9-19. doi: 10.3109/02652049109021853.
3
Cyclophosphamide loaded albumin microspheres II. Release characteristics.环磷酰胺负载白蛋白微球II. 释放特性
J Microencapsul. 1990 Oct-Dec;7(4):511-6. doi: 10.3109/02652049009040474.
4
Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.通过乳液溶剂蒸发法和乳液非溶剂添加法制备的含茶碱醋酸丁酸纤维素微球的微观性质及释放行为
Arch Pharm Res. 2009 Jul;32(7):1019-28. doi: 10.1007/s12272-009-1707-y. Epub 2009 Jul 31.
5
Clarithromycin targeting to lung: optimization of the size, morphology and release characteristics of albumin microspheres.靶向肺部的克拉霉素:白蛋白微球大小、形态及释放特性的优化
Acta Pol Pharm. 2000 Sep-Oct;57(5):375-80.
6
Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation.西咪替丁漂浮微球:制剂、表征及体外评价
Acta Pharm. 2005 Sep;55(3):277-85.
7
Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug.通过膜乳化技术制备均匀尺寸的壳聚糖微球及其作为蛋白质药物载体的应用。
J Control Release. 2005 Aug 18;106(1-2):62-75. doi: 10.1016/j.jconrel.2005.04.005.
8
Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).含葡萄球菌激酶变体(K35R)的聚乳酸-羟基乙酸共聚物微球的制备与表征
Yao Xue Xue Bao. 2006 Jan;41(1):12-8.
9
Localized rifampicin albumin microspheres.局部用利福平白蛋白微球
J Microencapsul. 1991 Jan-Mar;8(1):87-93. doi: 10.3109/02652049109021862.
10
Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.用于潜在肌肉注射的载酮咯酸氨丁三醇白蛋白微球的制备与评价
AAPS PharmSciTech. 2007 Feb 23;8(1):14. doi: 10.1208/pt0801014.